Self-pushing hemostatic gauze/dressing
A technology of hemostatic gauze and weak acid and strong base salt, which is applied in the fields of medical science, absorbent pads, pharmaceutical formulations, etc., can solve the problems of difficult and irregular surface sealing of wounds, expensive solid tissue sealants, etc., achieves good hemostatic effect, is easy to prepare and Effects of use, flexibility preparation and use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0085] CaCO 3 The preparation method of the particles is as follows: 0.33M Na 2 CO 3 Add to an equal volume of 0.33M CaCl 2 Medium and rapid mixing at 400 or 800 rpm, the precipitated CaCO 3 The particles can be purified by centrifugation (3,000 g, 10 min), and after washing three times with deionized water, the CaCO 3 Granules, freeze, dry in vacuum (-70°C, 30 Pascal) to constant weight; get CaCO 3 Microparticles (approximately 100 or 50 μm in size)
[0086] C-CaCO 3 Particles can be produced by Alfa Aesar, ACS grade, CaCO with a particle size of about 150 μm 3 particle.
[0087] The fibrinogen concentrate (containing coagulation factor XIII) can be RiaSTAP produced by CSL Behring.
[0088] Thrombin can be selected from the thrombin produced by Haematologic Technologies (specific activity = 3,650 U / mg.
[0089] TXA-NH 3 + The preparation method is:
[0090] Add 6M HCl to 0.5M tranexamic acid (TXA-NH 2 ) in aqueous solution up to pH 4.3. The acidified solution wa...
Embodiment 1-1
[0094] Example 1-1, CaCO loaded with fibrinogen 3 The preparation method of granular gauze, carries out following steps successively:
[0095] 1) Add the fibrinogen concentrate to the 10mM HEPES (4-hydroxyethylpiperazineethanesulfonic acid) aqueous solution according to the feed concentration of 20mg / ml to obtain a mixed solution;
[0096] 2), 329.5mg commercial or self-made CaCO 3 Particles (1-200 μm) are mixed with 3.295 ml of the mixture obtained in step 1) to obtain a mixture;
[0097] Pour the mixture over a 5 x 5cm 2 Gauze, frozen at -70 °C, and vacuum-dried at 30 Pa to constant weight; CaCO loaded with fibrinogen 3 Granular gauze.
[0098] Description: HEPES has a protective effect on the activity of fibrinogen.
Embodiment 1-2
[0099] Embodiment 1-2, the preparation method of gauze containing protonated tranexamic acid, the following steps are carried out successively:
[0100] Add 6M HCl to 0.5M tranexamic acid (TXA-NH2 ) in aqueous solution up to pH 4.3. The acidified solution was frozen at -70 °C at 30 Pa and vacuum dried to constant weight to obtain solid TXA-NH 3 + .
[0101] The TXA-NH 3 + with CaCO 3 The reaction produces bubbles of carbon dioxide, which it uses to propel itself.
[0102] 329.5mg TXA-NH 3 + Dissolve in 3.4ml water, then pour on 5×5cm 2 On 4 layers of gauze, freeze at -70°C and vacuum-dry at 30 Pascals to constant weight to obtain gauze containing protonated tranexamic acid.
PUM
Property | Measurement | Unit |
---|---|---|
particle diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com